Click on image to register at Early Rates!
Executives from the following companies have already registered for Neurotech 2008:

Aberdare Ventures
Accera, Inc.
Aculight Corporation
Adlyfe, Inc.
Advanced Neuromodulation Systems

Afferent Corporation
Aleva Neurotherapeutics
Alseres Pharmaceuticals
Alzheimer's Drug Discovery Foundation
Amnestix
Apnex Medical, Inc.
Apredica
Arboretum Ventures
Aspect Medical Systems, Inc.
Autonomic Technologies, Inc.
Avanir Pharmaceuticals
Avigen
Banyan Biomarkers
Bay City Capital
BG Medicine
Biogen Idec
BiotechPartnering Solutions, LLC
Boston Scientific
Boston Scientific Neuromodulation
Brain Research Group
BrainCells, Inc.
Brainsway LTD
Bristol-Myers Squibb
Cambria Pharmaceuticals
Cambridge BioPartners
CCC Medical Devices
Ceregene, Inc.
CIMIT
Cleveland Clinic Innovations
CNSBio Pty Ltd
Codman, Johnson & Johnson
Cognitive Drug Research
Concordant Rater Systems
Cortex Pharmaceuticals, Inc.
Cyberkinetics Neurotechnology Systems
Cyberonics
Cypress Bioscience, Inc.
Cytox Group
De Novo Ventures
DePuy - Codman
Deringer-Ney Inc.
Electrical Geodesics, Inc
Embera NeuroTherapeutics
Enteromedics
EnVivo Pharmaceuticals Inc.
Epilepsy Therapy Project
EPIX Pharmaceuticals
Ernest Gallo Clinic and Research Center
Ethicon, Inc.
Eurand
Evotec AG
Feinstein Kean Healthcare
FHC, Inc.
Flagship Ventures
Flanders Investment and Trade
Flint Hills Scientific, L.L.C.
Functional Neuroscience
Genentech, Inc.
Genesys Capital
Goldman, Sachs & Co.
HLM Venture Partners
Hoffman-LaRoche
IDSC, LLC
Inc. Magazine
Intelect Medical
International Neuromodulation Society
Intra-Cellular Therapies, Inc.
Jazz Pharmaceuticals
Johns Hopkins University
Johnson & Johnson
K&L Gates
Kappametrics Inc.
Limerick BioPharma
Liverpool University
Mass High Tech
Massachusetts Institute of Technology
McGovern Institute for Brain Research
McGovern Institute Neurotech Program
McLean Hospital
MedAvante
MedGenesis Therapeutics
MedTech Development LLC
Medtronic of Canada
Medtronic, Inc.
Merck & Co, Inc.
MHCA
MicroTransponder Inc.
MIT Media Lab
NASDAQ OMX
NDI Medical
NeuroHealing Pharmaceuticals
NeuroInsights
Neuronascent Inc
Neuronetics, Inc.
Neuronetrix, Inc.
NeuroNexus Technologies
Neuroquest Therapeutics
NeuroSigma, Inc.
Neurotech Reports
Neurotechnology Industry Organization
NeuroVentures
New Jersey Angels
New York Times
NIH/NINDS
Northstar Neuroscience
Norwich Ventures
Novartis Pharma
NsGene
Obiter Research
Omneuron
Orexigen
Oxford Bioscience Partners
Pappas Ventures
Pfizer
Picower Institute at MIT
Polaris Venture Partners
Posit Science Corporation
Probiodrug AG
Proteus Biomedical
PsychoGenics Inc.
RA Capital Management, LLC
Reckitt Benckiser Pharmaceuticals
Remedy Pharmaceuticals
Repligen Corporation
Sarentis Therapeutics
Satoris
Sepracor, Inc.
Somaxon Pharmaceuticals
Sound Pharmaceuticals
Stanford University
Sunstone Capital
Supernus Pharmaceuticals, Inc.
Targacept
Technology Partners
The Boston Globe
The Cleveland Clinic
The Epilepsy Prize
The Foundry
The Gray Sheet
The Pink Sheet Daily
The Scientist
toBBB
Traxion Therapeutics Inc
UCLA
USG
Versant Ventures
WGBH/NOVA Science Unit
Xytis Inc.
Yaupon Therapeutics
Zarlink Semiconductor